Navigation Links
Mark G. Mishek Is New President and CEO of Hazelden
Date:8/25/2008

Hazelden Board of Trustees Names Long-Time Twin Cities Health Care

Executive

MINNEAPOLIS, Aug. 25 /PRNewswire/ -- Mark G. Mishek, a Minnesota native with extensive executive-level experience in health care, was named Monday as President and CEO of Hazelden, the national non-profit organization that helps people reclaim their lives from addiction. The appointment was made by the Hazelden Board of Trustees.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080825/AQM518)

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/CGTU038LOGO)

Mishek comes to Hazelden from Allina Hospitals & Clinics, where he was most recently President of United Hospital of St. Paul and an Allina senior vice president. Mishek succeeds Ellen L. Breyer, who resigned in April.

"Mark Mishek has been a dynamic leader in health care in the Twin Cities for a long time," said Norb Conzemius, chairman of the Hazelden board. "He has demonstrated his ability to manage complex health care organizations. His contribution and level of commitment to service and quality patient care will provide a valuable asset to Hazelden as we grow and innovate to meet the challenges of treating addiction."

Mishek's career in health care spans 30 years. He has held positions with the Allina system since 1981, including Executive Vice President for Law & Public Affairs and General Counsel, and the Corporate Secretary for Allina Hospitals & Clinics.

"Hazelden is extremely fortunate to have appointed Mark as its new leader," said Ken Paulus, President & COO, Allina Hospitals & Clinics. "Mark is a tremendous advocate for those seeking treatment for addiction, and is committed to helping people from all walks of life battle this disease. His passion, as well as his remarkable engagement in public policy, makes him an ideal leader for Hazelden."

"Hazelden is an outstanding organization with a rich legacy and a bright future," said Mishek. "I am honored and grateful to have been chosen by the board to lead such a highly respected, mission-driven company. Hazelden truly is an international leader in helping people sustain lifelong recovery to addiction to alcohol and other drugs. I'm excited to build upon Hazelden's strong foundation, started 60 years ago, to assure that its messages of hope and recovery reach the broadest possible audience."

Mishek earned a bachelor's degree and a law degree from the University of Minnesota. He is currently chair of the St. Paul Area Chamber of Commerce and serves on the boards of Capital City Partnership and ClearWay Minnesota. He has been a past board member of the Portico Healthnet. He lives with his family in St. Paul and is in long-term recovery from the disease of addiction.

"Mark's professional expertise and personal experiences in recovery are an integral match to Hazelden's mission," said William Cope Moyers, Executive Director of Hazelden's Center for Public Advocacy.

Mishek is expected to assume his new duties on November 3, 2008.

About the Hazelden Foundation

Hazelden, a national nonprofit organization founded in 1949, helps people reclaim their lives from the disease of addiction. With nearly 60 years of knowledge and experience, Hazelden offers a comprehensive approach to addiction that addresses the full range of patient, family, and professional needs, including treatment and continuing care for youth and adults, research, higher learning, public education and advocacy, and publishing. It has facilities in Minnesota, Oregon, Illinois, and New York.


'/>"/>
SOURCE Hazelden
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation
2. Dale Magner Joins Guardian as Vice President
3. WellPoint Announces Appointments of Lori Beer as Executive Vice President and Chief Information Officer; Martin Miller as Senior Vice President, Chief Accounting Officer and Controller
4. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
5. Prematics Names Dean M. Panovich Vice President, Deployment
6. Sonic Innovations Appoints New President and COO
7. Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
8. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
9. Healthation Appoints New Vice President, Professional Services
10. WellPoint Appoints Krista A. Bowers as President of Senior Business
11. Pelosi Statement on Congress Sending Consumer Product Safety Legislation to President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , ... Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: A ... Results of the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, ... recognized for adherence to the highest standards of trauma, maternity, cancer and chronic ... center's president and CEO, Dr. Daniel Messina. , Among the recognitions, the American ...
(Date:12/8/2016)... ... ... Vida Health, the digital health platform that pairs individuals with ... . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. Vida ... are managing chronic conditions or simply want to improve their health. Canvas ...
(Date:12/8/2016)... ... ... Coppin Insurance Agency, an insurance and financial planning firm based in Lee ... is embarking on a charity drive with the goal of providing support and donations ... Bank of Southwest Florida works to provide fresh and nutritious food free of charge ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and Company ... of its phase 3 EXPEDITION3 trial at the 9 ... As previously disclosed, solanezumab did not meet the primary ... solanezumab initiated in people with mild dementia due to ... submissions for solanezumab for the treatment of mild dementia ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: